BRAF Mutation Class and Clinical Outcomes—Response

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-0422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BRAF Mutation Class and Clinical Outcomes—Letter

Clinical Cancer Research
Cancer ResearchOncology
2019English

Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-Mutant Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2018English

Clinical Outcomes of BRAF Plus MEK Inhibition in Melanoma: A Meta‐analysis and Systematic Review

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

BRAF Mutation as a Biomarker in Colorectal Cancer

Advances in Genomics and Genetics
2015English

BRAF G596R Mutation in a Slow-Progressing Melanoma

Pathology and Laboratory Medicine International
2015English

New Somatic BRAF Splicing Mutation in Langerhans Cell Histiocytosis

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

Desmoplastic Infantile Astrocytoma/Ganglioglioma With Rare BRAF V600D Mutation

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2016English

Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients

Neoplasma
Cancer Research
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy